Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07566286
NA

Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region

Sponsor: Galderma R&D

View on ClinicalTrials.gov

Summary

The primary objective of this study is to evaluate the safety of Restylane Lyft with Lidocaine for augmentation of the chin region 3 months after retreatment.

Official title: A Prospective, Multicenter Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile

Key Details

Gender

All

Age Range

22 Years - Any

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2026-06-03

Completion Date

2028-02-28

Last Updated

2026-08-14

Healthy Volunteers

Yes

Interventions

DEVICE

Restylane Lyft with Lidocaine

Sterile gel of hyaluronic acid.

Locations (8)

Galderma Investigational Site # 8680

Westport, Connecticut, United States

Galderma Investigational Site # 8774

Boynton Beach, Florida, United States

Galderma Investigational Site # 7030

Coral Gables, Florida, United States

Galderma Investigational Site # 8682

Coral Gables, Florida, United States

Galderma Investigational Site # 7042

Atlanta, Georgia, United States

Galderma Investigational Site # 7043

Bethesda, Maryland, United States

Galderma Investigational Site # 7118

Nashville, Tennessee, United States

Galderma Investigational Site # 8662

Spring, Texas, United States